Univariate | Mixed Model | |||
---|---|---|---|---|
β (95% CI)/Mean PhS (95% CI) | p | β (95% CI) | p | |
Gender (mean) | 0.14 | |||
Female | 44.5 (40.7 to 48.3) | |||
Male | 39.9 (34.9 to 44.8) | |||
Time of visit (weeks)a | <0.001 | <0.001 | ||
0 | 26.22 (22.04 to 30.39) | 35.46 (30.91 to 40.04) | ||
6 | 33.53 (29.43 to 37.63) | 38.38 (34.30 to 42.46) | ||
12 | 38.69 (34.59 to 42.79) | 39.95 (36.34 to 43.55) | ||
24 | 47.98 (43.76 to 52.19) | 43.57 (41.63 to 45.86) | ||
36 | 48.07 (43.81 to 52.32) | 44.62 (42.04 to 47.19) | ||
48 | 49.80 (45.54 to 54.05) | 44.29 (41.07 to 47.51) | ||
54 | 51.66 (47.40 to 55.91) | 46.51 (43.66 to 49.35) | ||
Age at onset | -0.01 (-0.97 to 0.95) | 0.98 | ||
Treatment (mean) b | 0.043 | 0.419 | ||
IFX+ MTX | 46.2 (41.0 to 50.5) | 0.046c | 40.19 (36.98 to 43.42) | |
Triple | 45.5 (40.4 to 50.5) | 0.065d | 42.70 (39.85 to 45.55) | |
MTX | 38.7 (33.5 to 43.9) | 42.65 (39.53 to 45.78) | ||
JADAS10 | -1.258 (-1.45 to -1.06) | <0.001 | -0.347(-0.72 to 0.024) | 0.067 |
Pain-VAS | -0.432 (-0.49 to -0.38) | <0.001 | -0.204 (-0.28 to -0.12) | <0.001 |
Corticosteroid usee | -0.473 (-0.64 to -0.30) | <0.001 | -0.004 (-0.019 to 0.10) | 0.554 |
Time in remissionf | 0.204 (0.073 to 0.334) | 0.003 | 0.172 (0.05 to 0.29) | 0.005 |
CHAQ | -23.25 (-26.1 to -20.4) | <0.001 | -11.2 (-15.8 to -6.67) | <0.001 |
CHAQ*JADAS | 0.087 (-0.29 to 0.47) | 0.658 |